+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Interleukin 8 receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin 8 receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Neonatal Fc receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Neonatal Fc receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Interleukin-12 expression stimulants - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin-12 expression stimulants - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Complement C3 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Complement C3 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
PD-1 and PD-L1 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

PD-1 and PD-L1 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 200 Pages
  • Global
From
Interleukin 6 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Interleukin 6 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Immunoglobulin inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Immunoglobulin inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
HIV integrase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

HIV integrase inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
SIMPONI Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SIMPONI Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Liposomal Cyclosporine A Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Liposomal Cyclosporine A Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Bertilimumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Bertilimumab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
US Alopecia Areata - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

US Alopecia Areata - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • November 2023
  • 115 Pages
  • United States
From
Ulcerative Colitis (UC) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Ulcerative Colitis (UC) - Epidemiology Forecast - 2032

  • Report
  • August 2023
  • 147 Pages
  • Global
From
Alopecia Areata - U.S Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Alopecia Areata - U.S Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • June 2023
  • 115 Pages
  • United States
From
ENSPRYNG Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ENSPRYNG Emerging Drug Insight and Market Forecast - 2032

  • Report
  • March 2023
  • 30 Pages
  • Global
From
Androgenetic Alopecia - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Androgenetic Alopecia - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 134 Pages
  • Global
From
Androgenetic Alopecia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Androgenetic Alopecia - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 67 Pages
  • Global
From
Global Endometriosis Pain - Pipeline Insight, 2022 - Product Thumbnail Image

Global Endometriosis Pain - Pipeline Insight, 2022

  • Drug Pipelines
  • August 2022
  • 60 Pages
  • Global
From
Antibody-Mediated Rejection - Epidemiology Forecast - 2032 - Product Thumbnail Image

Antibody-Mediated Rejection - Epidemiology Forecast - 2032

  • Report
  • August 2022
  • 78 Pages
  • Global
From
Antibody-Mediated Rejection - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Antibody-Mediated Rejection - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • August 2022
  • 157 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more